POSing the question: MARIPOSA-2, do the ends justify the means? Editorial

  

Authors:	Chen, M. F.; Piotrowska, Z.; Yu, H. A.
Title:	POSing the question: MARIPOSA-2, do the ends justify the means?
Keywords:	cancer survival; treatment response; exon; gene deletion; advanced cancer; cancer combination chemotherapy; cancer growth; drug efficacy; drug safety; risk benefit analysis; cancer patient; antineoplastic agent; progression free survival; blood toxicity; epidermal growth factor receptor; editorial; cancer resistance; gastrointestinal toxicity; survival time; egfr gene; cancer control; non small cell lung cancer; overall response rate; human; female; osimertinib; amivantamab; lazertinib
Journal Title:	Annals of Oncology
Volume:	35
Issue:	1
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2024-01-01
Start Page:	4
End Page:	6
Language:	English
DOI:	10.1016/j.annonc.2023.11.005
PUBMED:	37972893
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85179112698&doi=10.1016%2fj.annonc.2023.11.005&partnerID=40&md5=3cd0f8447a81aae5c9ad4965be903de5
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/213244